82 related articles for article (PubMed ID: 20847097)
1. FGF23: fashion or physiology?
Wolf M
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1727-9. PubMed ID: 20847097
[No Abstract] [Full Text] [Related]
2. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
[TBL] [Abstract][Full Text] [Related]
4. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.
Mirza MA; Larsson A; Melhus H; Lind L; Larsson TE
Atherosclerosis; 2009 Dec; 207(2):546-51. PubMed ID: 19524924
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery calcium: the cup is 96% full.
Hecht HS
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1184-6. PubMed ID: 19833307
[No Abstract] [Full Text] [Related]
6. PTH, FGF-23 and early CKD.
Rodriguez M; Felsenfeld AJ
Nephrol Dial Transplant; 2008 Nov; 23(11):3391-3. PubMed ID: 18676347
[No Abstract] [Full Text] [Related]
7. Chronic kidney disease as a potent risk modifier for CAD in diabetics.
Fink JC
JACC Cardiovasc Imaging; 2010 Jul; 3(7):746-8. PubMed ID: 20633853
[No Abstract] [Full Text] [Related]
8. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T.
Laufer EM; Mingels AM; Winkens MH; Joosen IA; Schellings MW; Leiner T; Wildberger JE; Narula J; Van Dieijen-Visser MP; Hofstra L
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1269-75. PubMed ID: 20299689
[TBL] [Abstract][Full Text] [Related]
9. Impact of fractional phosphate excretion on the relation of FGF23 with outcome in CKD patients.
Bech AP; Bouma-de Krijger A; van Zuilen AD; Bots ML; van den Brand JA; Blankestijn PJ; Wetzels JF; Vervloet MG
J Nephrol; 2015 Aug; 28(4):477-84. PubMed ID: 25700931
[TBL] [Abstract][Full Text] [Related]
10. Prognostic utility of coronary computed tomography angiography: are we looking at the correct outcomes and making appropriate comparisons?
Rassi A
JACC Cardiovasc Imaging; 2009 Jul; 2(7):914; author reply 915. PubMed ID: 19608143
[No Abstract] [Full Text] [Related]
11. Fetuin-A is not associated with mortality in chronic kidney disease.
Ix JH; Shlipak MG; Sarnak MJ; Beck GJ; Greene T; Wang X; Kusek JW; Collins AJ; Levey AS; Menon V
Kidney Int; 2007 Dec; 72(11):1394-9. PubMed ID: 17882149
[TBL] [Abstract][Full Text] [Related]
12. Relation between fetuin-A levels and fibroblast growth factor 23 with the severity of coronary artery disease measured by SYNTAX scores.
Chen YC; Lin FY; Lin RH; Chuang CL; Chang CC; Tsai CS
Am J Cardiol; 2013 Oct; 112(7):950-3. PubMed ID: 23795812
[TBL] [Abstract][Full Text] [Related]
13. Strengths and weaknesses of renal markers as risk factors and surrogate markers.
Johnson KR
Kidney Int; 2011 Jun; 79(12):1272-4. PubMed ID: 21625257
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
[TBL] [Abstract][Full Text] [Related]
15. Association between kidney dysfuction and the severity of coronary and aortic atherosclerosis.
Momiyama Y; Ohmori R; Fayad ZA; Tanaka N; Kato R; Taniguchi H; Nagata M; Ohsuzu F
Atherosclerosis; 2012 Aug; 223(2):523-6. PubMed ID: 22770127
[No Abstract] [Full Text] [Related]
16. Fibroblast growth factor 23 and the future of phosphorus management.
Wolf M
Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):463-8. PubMed ID: 19770756
[TBL] [Abstract][Full Text] [Related]
17. Soluble klotho and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
Brandenburg VM; Kleber ME; Vervloet MG; Larsson TE; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
Atherosclerosis; 2015 Oct; 242(2):483-9. PubMed ID: 26298739
[TBL] [Abstract][Full Text] [Related]
18. Glomerular filtration rate is associated with burden of coronary atherosclerosis in patients with acute coronary syndrome.
Duran M; Uysal OK; Gunebakmaz O; Baran O; Turfan M; Ornek E; Cetin M; Murat SN; Yarlioglues M; Karadeniz M; Kurtul A; Kaya MG
Angiology; 2014 Apr; 65(4):350-6. PubMed ID: 23636853
[TBL] [Abstract][Full Text] [Related]
19. Combined assessment of chronic kidney disease and subclinical peripheral artery disease used to predict future cardiac events.
Itaya H; Shiba M; Joki N; Nakamura M
Nephrology (Carlton); 2010 Mar; 15(2):230-5. PubMed ID: 20470284
[TBL] [Abstract][Full Text] [Related]
20. CT angiography in children: it is accurate, but is it safe?
Boxt LM
JACC Cardiovasc Imaging; 2008 May; 1(3):340-2. PubMed ID: 19356446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
